Nutrition intervention: A strategy against systemic inflammatory syndrome

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 4, 2009, Pages 380-389

  Oz, Helieh S ^a   Chen, Theresa S ^b   Neuman, Manuela ^c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cysteine; Docosahexaenoic acid; Eicosapentaenoic acid; Enteral formula; Probiotic fructooligosaccharides; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; CASEIN; CYSTEINE; DOCOSAHEXAENOIC ACID; FRUCTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OMEGA 3 FATTY ACID; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIE; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; DRUG LIVER LEVEL; ENZYME RELEASE; FIBER; HEMATOCRIT; LIQUID; LIVER CELL DAMAGE; LIVER DISEASE; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SOYBEAN; STOMACH PROTECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION; WHEY;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; CRITICAL ILLNESS; CYSTEINE; CYTOKINES; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENTERAL NUTRITION; HUMANS; LIPOPOLYSACCHARIDES; LIVER; MALE; OLIGOSACCHARIDES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; SHOCK, SEPTIC;

ANIMALIA; RATTUS;

EID: 67649240514     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108327194     Document Type: Article

References (59)

1. Angus DC, Linde-Zwirble WT, Lidicker J., Clermont G., Carcillo J., Pinsky MR Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29: 1303-1310. (Pubitemid 32641789)
2. Balk RA Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon. 2004 ; 50: 168-213. (Pubitemid 38595572)
3. Su GL Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol. 2002 ; 283: G256 - G265.
4. Fukui H., Brauner B., Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol. 1991 ; 12: 162-169.
5. Hanck C., Rossol S., Bocker U., Tokus M., Singer MV Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol. 1998 ; 33: 606-608. (Pubitemid 28548387)
6. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW Increased intestinal permeability associated with infection in burn patients. Arch Surg. 1988 ; 123: 1313-1319. (Pubitemid 18262710)
7. Parlesak A., Schafer C., Schutz T., Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000, 32: 742-747. (Pubitemid 30262733)
8. Han DW Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol. 2002 ; 8: 961-965.
9. Albillos A., de la Hera A., Gonzalez M., et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003 ; 37: 208-217. (Pubitemid 36042162)
10. Kaser A., Ludwiczek O., Waldenberger P., Jaschke W., Vogel W., Tilg H. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver. 2002 ; 22: 380-387. (Pubitemid 35331398)
11. Kamimura S., Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology. 1995 ; 22: 1304-1309.
12. Scapa E., Orda R., Neuman M., Sayfan J., Abramovici J., Eshchar J. B-N-acetyl hexosaminidase (B-NAH) serum levels after endotoxin administration into the portal vein in the rat. Liver. 1991 ; 11: 3941.
13. Szabo G., Romics L. Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002 ; 6: 1045-1066. (Pubitemid 36026462)
14. Ramadori G., Hopf U., Meyer zum Buschenfelde KH Binding sites for endotoxic lipopolysaccharide on the plasma membrane of isolated rabbit hepatocytes. Acta Hepatogastroenterol (Stuttg). 1979 ; 26: 368-374. (Pubitemid 10188081)
15. Neuman MG, Benhamou JP, Marcellin P., et al. Cytokinechemokine and apoptotic signatures in patients with chronic hepatitis C. Transl Res. 2007 ; 149: 126-136. (Pubitemid 46298834)
16. Schafer C., Schips I., Landig J., Bode JC, Bode C. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol. 1995 ; 33: 503-508.
17. Jain V., Halle A., Halmen KA, et al. Phagocytosis and intracellular killing of MD-2 opsonized gram-negative bacteria depend on TLR4 signaling. Blood. 2008 ; 111: 4637-4645.
18. Urbaschek R., McCuskey RS, Rudi V., et al. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res. 2001 ; 25: 261-268. (Pubitemid 32167443)
19. Neuman M., Cytokines: central factors in alcoholic liver disease. Alcohol Res Health. 2003 ; 27: 307-316. (Pubitemid 40685570)
20. Shi ZZ, Osei-Frimpong J., Kala G., et al. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci USA. 2000 ; 97: 5101-5106. (Pubitemid 30313678)
21. Cotgreave IA, Grafstr?¶m RC, Mold?©us P. Modulation of pneumotoxicity by cellular glutathione and precursors. Bull Eur Physiopathol Respir. 1986 ; 22: 263s - 266s. (Pubitemid 16155856)
22. Lieber CS Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta. 1997 ; 257: 59-84. (Pubitemid 27055895)
23. Oz HS, Chen TS, McClain CJ, de Villiers WJS. Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem. 2005 ; 16: 297-304. (Pubitemid 41556919)
24. Oz HS, McClain C., Nagasawa H., Ray M., Chen T. Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Tox. 2004 ; 18: 361-368. (Pubitemid 40165439)
25. Oz HS, Chen T., Nagasawa H. Comparative efficacies of two cysteine prodrugs and a glutathione delivery agent in a colitis model. Trans Res. 2007 ; 150: 122-129. (Pubitemid 47081449)
26. Oz HS, Im H., Chen T., McClain C., de Villiers WJS. Glutathione- enhancing agents protect against steatohepatitis in a dietary model. J Biochem Mol Toxicol. 2006 ; 20: 39-47. (Pubitemid 43291269)
27. Oz HS, Chen T., de Villiers WJ, McClain CJ Metallothionein over-expression does not protect against inflammatory bowel disease in a murine colitis model. Med Sci Monit. 2005 ; 11: BR69 - BR73.
28. Robinson MK, Rounds JD, Hong RW, Jacobs DO, Wilmore DW Glutathione deficiency increases organ dysfunction after hemorrhagic shock. Surgery. 1992 ; 112: 140-147.
29. Mrtensson J., Jain A., Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA. 1990 ; 87: 1715-1719.
30. Brun P., Castagliuolo I., Di Leo V., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007 ; 292: G518 - G525.
31. Kaplowitz N., Fernández-Checa JC, Kannan R., García-Ruiz C., Ookhtens M., Yi JR GSH transporters: molecular characterization and role in GSH homeostasis. Biol Chem Hoppe Seyler. 1996 ; 377: 267-273.
32. Kaplowitz N., Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis. 1996 ; 14: 131-159. (Pubitemid 26381338)
33. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999 ; 27: 1409-1420. (Pubitemid 29406926)
34. Martin CR, Walker WA Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol. 2008 ; 32: 127-137.
35. Oz HS, Ray M., Chen T., McClain C. Efficacy of a TGF-22 containing nutritional support formula in a murine model of IBD. J Am Coll Nutr. 2004 ; 23: 220-226.
36. Calder PC n-3 fatty acids, inflammation, and immunity: relevance to postsurgical and critically ill patients. Lipids. 2004 ; 39: 1147-1161.
37. Breen HB, Espat NJ The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr. 2004 ; 28: 272-277. (Pubitemid 38812683)
38. Barber MD Cancer cachexia and its treatment with fish oil enriched nutritional supplementation. Nutrition. 2001 ; 17: 751-755. (Pubitemid 32821144)
39. Covington MB Omega-3 fatty acids. Am Fam Physician. 2004 ; 70: 133-140. (Pubitemid 38890768)
40. Mead A., Atkinson G., Albin D., et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease: evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet. 2006 ; 19: 401-419. (Pubitemid 44741532)
41. Michaeli B., Berger MM, Revelly JP, Tappy L., Chiolero R. Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr. 2007 ; 26: 70-77. (Pubitemid 46179108)
42. Cooper AL, Gibbons L., Horan MA, Little RA, Rothwell NJ Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin Nutr. 1993 ; 12: 321-328. (Pubitemid 24006127)
43. Schwab JM, Chiang N., Arita M., Serhan CN Resolvin E1 and protectin D1 activate inflammation-resolution programmes. 2007 ; 447: 869-874.
44. Li Z., Yang S., Lin H., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003 ; 37: 343-350. (Pubitemid 36152533)
45. Beutler B., Kruys V. Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J Cardiovasc Pharmacol. 1995 ; 25 (suppl 2). S1 - S8.
46. Mackensen A., Galanos C., Wehr U., Engelhardt R. Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw. 1992 ; 3: 571-579.
47. Shikora SA, Martindale RG, Schwarzberg SD, eds. Nutritional Considerations in the Intensive Care Unit. Dubuque, IA: Kendall/ Hunt ; 2002.
48. Rajan S., Buchman TG, Coopersmith CM, et al. Intestine specific over-expression of IL-10 improves survival in a polymicrobial model of sepsis. Crit Care Med. 2005 ; 33 (suppl): A133.
49. Tessari P., Kiwanuka E., Cristini M., et al. Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes. Diabetes Metab Res Rev. 2007 ; 23: 378-385. (Pubitemid 47091241)
50. Ledesma Castano F., Echevarria Vierna S., Lozano Polo JL, Oloriz Rivas R., Alvarez Moreno C., Pons Romero F. Interleukin-1 in alcoholic cirrhosis of the liver: the influence of nutrition. Eur J Clin Nutr. 1992 ; 46: 527-533.
51. Loi C., Osowska S., Neveux N., Darquy S., Cynober L., Moinard C. Effects of an immune-enhancing diet in endotoxemic rats. Nutrition. 2004 ; 21: 255-263.
52. Vary TC, Lynch CJ Nutrient signaling components controlling protein synthesis in striated muscle. J Nutr. 2007 ; 137: 1835-1843. (Pubitemid 47292726)
53. Fang XL, Zhang YT, Fang Q. Impact of intravenous nutrition on plasma free amino acid spectrum and immune function for patients with sepsis. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 ; 36: 298-302.
54. Cribb PJ, Williams AD, Carey MF, Hayes A. The effect of whey isolate and resistance training on strength, body composition, and plasma glutamine. Int J Sport Nutr Exerc Metab. 2006 ; 16: 494-509. (Pubitemid 44520663)
55. Boirie Y., Dangin M., Gachon P., Vasson MP, Maubois JL, Beaufrère B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci USA. 1997 ; 94: 14930-14935. (Pubitemid 28041477)
56. Yermolaieva O., Xu R., Schinstock C., et al. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc Natl Acad Sci USA. 2004 ; 101: 1159-1164. (Pubitemid 38182659)
57. Oz HS, Ebersole JL Application of prodrugs to inflammatory diseases of the gut [review]. Molecules. 2008 ; 13: 452-474.
58. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology. 1992 ; 103: 186-196.
59. Kaufmann I., Hoelzl A., Schliephake F., et al. Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock. 2007 ; 27: 25-31. (Pubitemid 44968006)